BCG remains the only widely available vaccine for TB. Yet the development of a COVID-19 vaccine over the last year shows that there is capacity to rapidly create new vaccines.
Emily B. Wong, Africa Health Research Institute (AHRI) and Alison Grant, Africa Health Research Institute (AHRI)
South Africa’s long-awaited TB prevalence survey results were recently released. They reveal that the country has a much higher burden of TB than previously thought.